Strata Critical Medical, Inc. Class A Common Stock (SRTA) Q1 2025 Earnings
Strata Critical Medical, Inc. Class A Common Stock reported Q1 2025 revenue of $54.3M (+5.4% YoY), missed analyst consensus of $65.8M by $11.5M. Diluted EPS came in at $-0.04 (+33.3% YoY), beat the $-0.11 consensus by $0.07.
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Strata Critical Medical, Inc. Class A Common Stock's Q1 2025 earnings report.
Strata Critical Medical, Inc. Class A Common Stock (SRTA) reported Q1 2025 earnings on May 12, 2025 before market open.
Strata Critical Medical, Inc. Class A Common Stock reported revenue of $54.3M and diluted EPS of $-0.04 for Q1 2025.
Revenue missed the consensus estimate of $65.8M by $11.5M. EPS beat the consensus estimate of $-0.11 by $0.07.
Compared to the same quarter a year prior, revenue grew 5.4% from $51.5M a year earlier and diluted EPS grew 33.3% from $-0.06.
You can read the 10-Q periodic report (0001779128-25-000042) directly on SEC EDGAR. The filing index links above go to sec.gov.